Clinical Trial Update: Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial evaluating Cellistem-OA for knee osteoarthritis. The update indicates the study status as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Cellistem-OA

Snippet

Sponsor: Universidad de los Andes, Chile | Conditions: Osteoarthritis, Knee | Phase 1 | Status: UNKNOWN